Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Document Type
- Journal article (16) (remove)
Language
- English (16)
Keywords
- blood–brain barrier (6)
- endothelial cells (4)
- tight junctions (3)
- age-related hearing loss (2)
- blood-brain barrier (2)
- blood–labyrinth barrier (2)
- cEND (2)
- heart failure (2)
- in vitro (2)
- inflammation (2)
- neurotrophins (2)
- spiral ganglion neuron (2)
- Alzheimer's disease (1)
- Alzheimer’s disease (1)
- BDNF (1)
- Blut-Hirn-Schranke (1)
- CNS diseases (1)
- CNS disorders (1)
- CNS injury (1)
- GDNF (1)
- Glucosetransportproteine (1)
- IL-6 (1)
- IL6 (1)
- MK801 (1)
- NF-kappa-B (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMDAR (1)
- PIK3R1 (1)
- Schlaganfall (1)
- TNF-α (1)
- TTFields (1)
- TTS (1)
- Takotsubo syndrome (1)
- aging (1)
- alzheimer's disease (1)
- amyloid cardiomyopathy (1)
- angiogenesis (1)
- approved drugs (1)
- astrocytes (1)
- barrier (1)
- barrier properties (1)
- blood (1)
- blood brain barrier (1)
- brain (1)
- brain pathology (1)
- calcium level (1)
- cell stretch (1)
- central nervous system (1)
- cerebEND (1)
- cerebral ischemia (1)
- chemical similarity (1)
- corticosteroids (1)
- cytokine expression (1)
- dexamethasone (1)
- diabetes mellitus (1)
- diabetic nephropathy (1)
- diabetic retinopathy (1)
- drug repurposing (1)
- drug transporter (1)
- exposure (1)
- expression (1)
- fetal lung (1)
- glucocorticoid receptor (1)
- glucocorticoids (1)
- glut1 (1)
- human (1)
- immortalization (1)
- immunology (1)
- in vitro cell culture models (1)
- in vitro model (1)
- inner ear (1)
- ischemia (1)
- isosteviol sodium (STVNA) (1)
- kidney ischemia/reperfusion injury (1)
- lipids (1)
- microRNA (1)
- microvascular complications (1)
- microvascular endothelial cells (1)
- molecular modeling (1)
- mouse models (1)
- necrosis factor alpha (1)
- nervous system (1)
- neuroscience (1)
- neurotrophic factor (1)
- neurovasculature (1)
- nitric oxide (1)
- oxygen-glucose deprivation (1)
- patient (1)
- pharmacotherapy (1)
- phosphatidylinositol (1)
- pregnancy (1)
- preterm birth (1)
- protein expression (1)
- rat (1)
- receptor antagonist (1)
- scaffold search (1)
- senescence (1)
- sglt1 (1)
- sheep (1)
- stroke (1)
- subarachnoid hemorrhage (1)
- traumatic brain injury (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (16)
- Institut für Anatomie und Zellbiologie (4)
- Neurochirurgische Klinik und Poliklinik (3)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Kinderklinik und Poliklinik (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Medizinische Klinik und Poliklinik I (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
EU-Project number / Contract (GA) number
- 241778 (3)
- HEALTH-F2-2009-241778 (1)
Objective
Plasminogen activator inhibitor-1 (PAI-1) is the key endogenous inhibitor of fibrinolysis, and enhances clot formation after injury. In traumatic brain injury, dysregulation of fibrinolysis may lead to sustained microthrombosis and accelerated lesion expansion. In the present study, we hypothesized that PAI-1 mediates post-traumatic malfunction of coagulation, with inhibition or genetic depletion of PAI-1 attenuating clot formation and lesion expansion after brain trauma.
Methods
We evaluated PAI-1 as a possible new target in a mouse controlled cortical impact (CCI) model of traumatic brain injury. We performed the pharmacological inhibition of PAI-1 with PAI-039 and stimulation by tranexamic acid, and we confirmed our results in PAI-1–deficient animals.
Results
PAI-1 mRNA was time-dependently upregulated, with a 305-fold peak 12 hours after CCI, which effectively counteracted the 2- to 3-fold increase in cerebral tissue-type/urokinase plasminogen activator expression. PAI-039 reduced brain lesion volume by 26% at 24 hours and 43% at 5 days after insult. This treatment also attenuated neuronal apoptosis and improved neurofunctional outcome. Moreover, intravital microscopy demonstrated reduced post-traumatic thrombus formation in the pericontusional cortical microvasculature. In PAI-1–deficient mice, the therapeutic effect of PAI-039 was absent. These mice also displayed 13% reduced brain damage compared with wild type. In contrast, inhibition of fibrinolysis with tranexamic acid increased lesion volume by 25% compared with vehicle.
Interpretation
This study identifies impaired fibrinolysis as a critical process in post-traumatic secondary brain damage and suggests that PAI-1 may be a central endogenous inhibitor of the fibrinolytic pathway, promoting a procoagulatory state and clot formation in the cerebral microvasculature. Ann Neurol 2019;85:667–680